HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ran Zhu Selected Research

1- (hydroxymethyl)- 3- (3- octylphenyl)cyclobutane

9/2011Characterization of a sphingosine 1-phosphate receptor antagonist prodrug.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ran Zhu Research Topics

Disease

14Neoplasms (Cancer)
03/2024 - 09/2011
7Breast Neoplasms (Breast Cancer)
01/2022 - 09/2011
3Disseminated Intravascular Coagulation
01/2023 - 07/2009
3Thrombosis (Thrombus)
01/2022 - 02/2017
3Lymphatic Metastasis
01/2022 - 06/2014
3Sepsis (Septicemia)
12/2017 - 07/2009
2Shock
03/2024 - 12/2022
2Amyloid Plaque
08/2023 - 01/2016
2Acute Kidney Injury (Acute Renal Failure)
01/2023 - 07/2009
2Hypoxia (Hypoxemia)
01/2022 - 01/2022
2Inflammation (Inflammations)
01/2020 - 11/2005
2Neoplasm Metastasis (Metastasis)
01/2015 - 06/2014
2Multiple Organ Failure (MODS)
07/2009 - 09/2006
2Lymphopenia (Lymphocytopenia)
12/2007 - 11/2005
1AIDS-Related Complex (ARC)
03/2024
1Mental Disorders (Mental Disorder)
01/2024
1Anorexia Nervosa
01/2024
1Hypersensitivity (Allergy)
01/2024
1Food Hypersensitivity (Food Allergy)
01/2024
1Glaucoma
01/2024
1Cataract (Cataracts)
01/2024
1Spinal Cord Injuries (Spinal Cord Injury)
11/2023
1Cytomegalovirus Infections (Inclusion Disease)
10/2023
1Non-alcoholic Fatty Liver Disease
10/2023
1Atherosclerosis
10/2023
1Hepatitis B
10/2023
1Hepatitis C
10/2023
1Dementia (Dementias)
08/2023
1Peripheral Nerve Injuries
01/2023
1Fatigue
12/2022
1Pulmonary Embolism
01/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2021
1Triple Negative Breast Neoplasms
01/2021

Drug/Important Bio-Agent (IBA)

4Radioisotopes (Radionuclides)IBA
03/2024 - 01/2021
4Therapeutic UsesIBA
10/2023 - 07/2009
2AlloysIBA
03/2024 - 12/2022
2FibrinolysinFDA Link
01/2022 - 01/2022
2Serine Proteases (Serine Protease)IBA
01/2022 - 01/2022
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2022 - 01/2022
2Messenger RNA (mRNA)IBA
01/2022 - 06/2014
2PlasminogenIBA
01/2022 - 01/2022
2NaGdF4IBA
01/2022 - 11/2018
2RadiopharmaceuticalsIBA
10/2021 - 01/2021
2PolymersIBA
10/2021 - 01/2021
2Phosphotransferases (Kinase)IBA
01/2020 - 11/2005
2Glucose (Dextrose)FDA LinkGeneric
01/2020 - 12/2013
2Heparin (Liquaemin)FDA LinkGeneric
12/2017 - 07/2009
2TamoxifenFDA LinkGeneric
07/2017 - 04/2013
2Dacarbazine (DIC)FDA LinkGeneric
02/2017 - 07/2009
2Proteins (Proteins, Gene)FDA Link
06/2014 - 06/2014
1PlasticsIBA
03/2024
1AluminumIBA
03/2024
1Peptides (Polypeptides)IBA
03/2024
1Immune Checkpoint InhibitorsIBA
03/2024
1Biomarkers (Surrogate Marker)IBA
03/2024
1OvalbuminIBA
01/2024
1AllergensIBA
01/2024
15' Untranslated Regions (5' UTR)IBA
11/2023
1hydrogen sulfite (bisulfite)IBA
11/2023
13' Untranslated Regions (3' UTR)IBA
11/2023
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
10/2023
1naringeninIBA
10/2023
1Caspase 3 (Caspase-3)IBA
10/2023
1LipidsIBA
10/2023
1asparaginylendopeptidase (legumain)IBA
08/2023
1Pyruvate Dehydrogenase (Lipoamide)IBA
01/2023
1EnzymesIBA
01/2023
1FibrinIBA
01/2023
1Fibrinogen (Factor I)FDA Link
01/2023
1fibrin fragment D (D-dimer)IBA
01/2023
1Pyruvic Acid (Pyruvate)IBA
01/2023
1Tricarboxylic AcidsIBA
01/2023
1Oxidoreductases (Dehydrogenase)IBA
01/2023
1TitaniumIBA
12/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022
1Chemokine CX3CL1IBA
01/2022
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
01/2022
1lactacystinIBA
01/2022
1Trastuzumab (Herceptin)FDA Link
01/2022
1Monoclonal AntibodiesIBA
01/2022
1Brain Natriuretic Peptide (Natrecor)FDA Link
01/2022
1UbiquitinIBA
01/2022
1Chelating AgentsIBA
01/2021
1MetalsIBA
01/2021
1gastric inhibitory polypeptide receptorIBA
01/2021
1pyridinium 3-methoxyestra-1,3,5(10)-trien-6-yl sulfate (PMTS)IBA
02/2020
1Toll-Like Receptor 4IBA
01/2020
1FructoseIBA
01/2020
1ChlorophyllIBA
11/2019
1PorphyrinsIBA
11/2019

Therapy/Procedure

8Therapeutics
03/2024 - 07/2009
3Lasers (Laser)
03/2024 - 11/2019
3Precision Medicine
01/2022 - 11/2019
2Radiotherapy
10/2021 - 12/2015
1Lenses
01/2024
1Critical Care (Surgical Intensive Care)
01/2023
1Photothermal Therapy
10/2021
1Photochemotherapy (Photodynamic Therapy)
11/2019